β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL-Reference-Cited by-同舟云学术

β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL

Published:2018-06-21 Issue:7 Volume:19 Page:1173-1182
ISSN:1399-543X
Container-title:Pediatric Diabetes
language:en
Short-container-title:Pediatr Diabetes

Author:

Nyirjesy Sarah C¹,Sheikh Saba²^ORCID,Hadjiliadis Denis³,De Leon Diva D⁴^ORCID,Peleckis Amy J¹,Eiel Jack N¹,Kubrak Christina²,Stefanovski Darko⁵,Rubenstein Ronald C²,Rickels Michael R¹^ORCID,Kelly Andrea⁴

Affiliation:

1. Division of Endocrinology, Diabetes & Metabolism, Department of Medicine; Hospital of the University of Pennsylvania; Philadelphia Pennsylvania

2. Division of Pulmonary Medicine, Department of Pediatrics; Children's Hospital of Philadelphia; Philadelphia Pennsylvania

3. Division of Pulmonary and Critical Care Medicine, Department of Medicine; Hospital of the University of Pennsylvania; Philadelphia Pennsylvania

4. Division of Endocrinology and Diabetes, Department of Pediatrics; Children's Hospital of Philadelphia; Philadelphia Pennsylvania

5. Department of Biostatistics; University of Pennsylvania School of Veterinary Medicine; Philadelphia Pennsylvania

Funder

Cystic Fibrosis Foundation

National Institute of Diabetes and Digestive and Kidney Diseases

Human Metabolism Resource of the University of Pennsylvania Institute for Diabetes, Obesity & Metabolism

University of Pennsylvania Training Grant in Diabetes, Endocrine and Metabolic Diseases

University of Pennsylvania Diabetes Research Center

Penn and CHOP Clinical & Translational Research Centers

Public Health Services Research Grants

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pedi.12700/fullpdf

Reference30 articles.

1. Origins of cystic fibrosis lung disease;Stoltz;N Engl J Med,2015

2. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality;Moran;Diabetes Care,2009

3. Epidemiology of cystic fibrosis-related diabetes;Marshall;J Pediatr,2005

4. Reduced beta-cell secretory capacity in pancreatic-insufficient, but not pancreatic-sufficient, cystic fibrosis despite normal glucose tolerance;Sheikh;Diabetes,2017

5. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review;Moran;Diabetes Care,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Observations in Patients With Cystic Fibrosis–Related Diabetes and Self-Reported Ototoxicity Symptoms;American Journal of Audiology;2023-11-28

2. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes;Frontiers in Endocrinology;2023-11-23

3. Advances in cystic fibrosis-related diabetes: Current status and future directions;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-11

4. Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional study;Frontiers in Endocrinology;2023-08-31

5. Preservation of β-cell Function in Pancreatic Insufficient Cystic Fibrosis With Highly Effective CFTR Modulator Therapy;The Journal of Clinical Endocrinology & Metabolism;2023-07-28